MIKA continues to booked solid performance in 9M21 with strong growth in both inpatient and outpatient segments. For upcoming quarters, we expect there will be normalization of margin and patient traffic volume after Covid-19 peak. Given its strong track record and balance sheet, we believe company’s strategic plan will be achievable.
Download full report HERE.
